Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Increase Continues In Supplement GMP Noncompliance

This article was originally published in The Tan Sheet

Executive Summary

The GMP noncompliance rate in the dietary supplement industry continued to increase in the first quarter of fiscal 2014 after reaching nearly 70% in fiscal 2013.

The good manufacturing practices noncompliance rate in the dietary supplement industry continued to increase in the first quarter of fiscal 2014, from 69.4% for all of 2013 to 72.1% in the October-December period of 2013, according to FDA’s Division of Dietary Supplement Programs data (see story, (Also see "Inspection Data Show “Reality” Of Supplement GMP Enforcement" - Pink Sheet, 21 Apr, 2014.)).

FDA Supplement GMP Inspections*

Fiscal Year

Inspections

% Found Noncompliant

% Official Action Indicated

% Voluntary Action Indicated

% No Action Indicated

2008

158

41.1

15.2

25.9

58.9

2009

162

43.2

14.8

28.4

56.8

2010

228

61.4

25.4

36

38.6

2011

353

75.0

36.8

38.2

30.6

2012

591

63.8

27.9

35.9

34.5

2013

585

69.4

28

41.4

30.6

2014 (Q1)

140

72.1

34.3

37.8

27.9

* FDA officials reported these figures as preliminary; from April 15 presentation at the International Conference on the Science and Regulation of Botanicals.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106847

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel